Steven C Wallis Selected Research

Meropenem (Merrem)

3/2022	Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samples.
1/2022	Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model.
1/2022	Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates.
1/2022	Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model.
1/2021	Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance.
12/2019	Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.
11/2019	A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study.
1/2018	Maximally effective dosing regimens of meropenem in patients with septic shock.
1/2017	Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.
11/2016	Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven C Wallis Research Topics

Disease

66	Critical Illness (Critically Ill) 03/2022 - 07/2010
26	Infections 08/2022 - 11/2011
15	Body Weight (Weight, Body) 01/2022 - 05/2015
12	Sepsis (Septicemia) 01/2022 - 12/2014
7	Septic Shock (Toxic Shock Syndrome) 01/2022 - 07/2015
6	Peritonitis 01/2022 - 08/2012
5	AIDS-Related Complex (ARC) 01/2021 - 01/2016
4	Acute Kidney Injury (Acute Renal Failure) 07/2021 - 09/2014
3	Pseudomonas Infections 01/2022 - 01/2018
3	Ventilator-Associated Pneumonia 01/2019 - 01/2018
3	Obesity 01/2017 - 01/2016
2	Intraabdominal Infections 01/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2020
2	Seizures (Absence Seizure) 01/2021 - 12/2012
1	Bacteremia 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Hypotension (Low Blood Pressure) 07/2021
1	Hemorrhage 07/2021
1	Hemorrhagic Shock 07/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Meningitis 12/2020
1	Hypoalbuminemia 01/2020
1	Pulmonary Embolism 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Infertility (Sterility) 07/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2016
1	Acute Lung Injury 12/2015
1	Wounds and Injuries (Trauma) 05/2015
1	Cross Infection (Nosocomial Infection) 01/2015
1	Chronic Renal Insufficiency 11/2014
1	Inflammation (Inflammations) 06/2012
1	Surgical Wound Infection 11/2011
1	Abdominal Aortic Aneurysm 11/2011

Drug/Important Bio-Agent (IBA)

27	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2011
17	Meropenem (Merrem)FDA LinkGeneric 03/2022 - 05/2013
14	CreatinineIBA 01/2022 - 11/2014
11	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 08/2022 - 05/2013
11	Pharmaceutical PreparationsIBA 01/2022 - 07/2010
9	Piperacillin FDA LinkGeneric 01/2022 - 07/2013
6	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022 - 01/2016
5	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022 - 12/2016
5	LactamsIBA 01/2022 - 04/2014
5	Cefazolin (Ancef)FDA LinkGeneric 05/2021 - 11/2011
4	Tobramycin (Nebcin)FDA LinkGeneric 01/2022 - 01/2018
4	Vancomycin FDA LinkGeneric 01/2022 - 05/2014
4	Fosfomycin FDA Link 01/2022 - 02/2015
3	AminoglycosidesIBA 01/2022 - 01/2016
3	Caspofungin (Cancidas)FDA Link 01/2022 - 02/2015
3	Amikacin (A.M.K)FDA LinkGeneric 01/2022 - 01/2016
3	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 09/2014
3	Micafungin (FK463)FDA Link 12/2021 - 01/2021
3	tazobactam drug combination ceftolozaneIBA 01/2021 - 12/2019
3	posaconazole FDA Link 06/2019 - 01/2018
3	beta-LactamsIBA 01/2018 - 07/2010
2	desacetylcefotaximeIBA 01/2022 - 07/2021
2	Cefotaxime (Kendrick)FDA LinkGeneric 01/2022 - 07/2021
2	Serum AlbuminIBA 01/2022 - 05/2015
2	Cefepime (Maxipime)FDA LinkGeneric 12/2021 - 12/2012
2	Tazobactam FDA LinkGeneric 10/2021 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2010
2	Fluconazole (Zonal)FDA LinkGeneric 11/2016 - 02/2015
2	Gentamicins (Gentamicin)FDA LinkGeneric 07/2016 - 08/2012
2	Doripenem FDA Link 01/2016 - 09/2014
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	ResveratrolIBA 07/2021
1	Methicillin (Metin)FDA Link 05/2021
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2021
1	Ertapenem (Invanz)FDA Link 01/2020
1	SolutionsIBA 01/2020
1	AlbuminsIBA 01/2020
1	Dialysis SolutionsIBA 12/2019
1	ceftolozaneIBA 10/2019
1	Ticarcillin (Tarcil)FDA Link 09/2019
1	beta-Lactamases (beta-Lactamase)IBA 01/2018
1	TriazolesIBA 01/2018
1	AS 8IBA 01/2017
1	beta Lactam AntibioticsIBA 10/2016
1	Icodextrin (Extraneal)FDA Link 07/2016
1	MelatoninIBA 03/2016
1	SmokeIBA 12/2015
1	Anidulafungin FDA Link 02/2015
1	Trace Elements (Biometals)IBA 06/2012
1	Floxacillin (Flucloxacillin)IBA 08/2010

Therapy/Procedure

12	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 12/2012
8	Extracorporeal Membrane Oxygenation 01/2022 - 10/2017
8	Therapeutics 01/2022 - 01/2018
8	Continuous Renal Replacement Therapy 12/2021 - 12/2012
4	Peritoneal Dialysis 07/2016 - 08/2012
1	Hemodiafiltration 12/2021
1	Resuscitation 01/2020
1	Critical Care (Surgical Intensive Care) 01/2020
1	Plasmapheresis 01/2020
1	Intravenous Administration 06/2019
1	Cannula 05/2019
1	Intravenous Infusions 01/2016
1	Length of Stay 11/2014